|
|
Eric Dutram: 2012 started off as a pretty solid year for the markets as equities rose across the board in the first quarter. However, the second quarter wasn’t nearly as friendly to investors as markets slumped thanks to a number of risks. Read more…
Ron Rowland: In a few short hours we should have some big news: A Supreme Court decision on the constitutionality of health care reform. Investors have a lot at stake. Whatever the court decides will be good for some Health Care stocks Read more…
Despite the recent economic turmoil in Europe, the Biotech Industry has been home to some of the strongest performers in the market in 2012. The SPDR S&P Biotech ETF (NYSEARCA:XBI) and the First Trust NYSE Arca Biotech Index ETF (NYSEARCA:FBT) year-to-date are up Read more…
Don Miller: Innovations in biotechnology are evolving at the speed of light. In fact, astonishing advancements in biotech have transformed the way we practice medicine. Leading-edge biotech products and breakthroughs are literally saving thousands of lives every day. Read more…
In trading on Friday, the iShares MSCI Emerging Markets EMEA (NASDAQ:EEME) is outperforming other ETFs, up about 2.11% on the day. Also up on the day is the Read more…
Benjamin Shepherd: Afflicted by a wave of patent expirations and several high-profile class-action lawsuits, the pharmaceutical industry has suffered its fair share of ailments in recent years. Accordingly, the S&P 500 Pharmaceuticals Index has returned a paltry 16.5 percent over the past half-decade. Read more…
In trading on Thursday, the iPath Global Carbon ETN (NYSEArca:GRN) is outperforming other ETFs, up about 13.04% on the day. Also up on the day are the Read more…
Stocks surged higher across the board on Tuesday on strong trade. All five major indices closed well in the black, with large cap issues leading the advance. By the closing bell the Nasdaq (NASDAQ:QQQ), S&P 500 (NYSEARCA:SPY) and the Dow Jones Industrial Average (NYSEARCA:DIA) posted Read more…
In trading on Monday, the iShares Nasdaq Biotechnology (NASDAQ:IBB) is outperforming other ETFs, up about 4.78% on the day. Also up on the day are the Read more…
NASDAQ:IBB, NYSE:BABS, NYSE:CRBI, NYSE:EMFN, NYSE:LGEM, NYSE:XBI
In trading on Thursday, the C-Tracks Citi Volatility Index TR ETN (NYSE:CVOL) is outperforming other ETFs, up about 35.28% on the day. Also up on the day are the Read more…
NASDAQ:IBB, NYSE:CVOL, NYSE:FBT, NYSE:VIXY, NYSE:VXX, NYSE:XBI
Ron Rowland: Like many of you, I’m a Baby Boomer. Now I find myself north of 50 and the prospect of getting “old” isn’t very attractive. What does this have to do with investing and ETFs? Plenty! Read more…
Equities performed well on Thursday pacing all five major indices well into positive territory. By the closing bell the S&P 500 (NYSE:SPY) tacked on 1.4% while the Dow Jones Industrial Average (NYSE:DIA) and small-cap Russell 2000 (NYSE:IWM) followed closely as both gained 1.2% Read more…
David Fry: Our goal in this profile is to help investors wade through the many competing ETF offerings available. Using our long experience as an ETF publication, and nearly 40 years in the investment business, we can help select those ETFs that matter and may or may not be repetitive. Read more…
NASDAQ:IBB, NYSE:FBT, NYSE:FXH, NYSE:IHF, NYSE:IYH, NYSE:PPH, NYSE:XBI, NYSE:XLV
As the equity markets continue to remain volatile and are highly susceptible to overall investor sentiment, it is important to consider certain sectors which are able to prosper in times of Read more…
On light volume, the major indices ended Friday’s session split. The blue chip Dow ended the year by posting a slim 0.1% gain on the session. The S&P 500 finished the day flat, while the Nasdaq, S&P Read more…
Most Comments